Fosamax, Alendronate News

A study published on bmj.com reports that monitoring bone mineral density in postmenopausal women taking osteoporosis drugs, such as bisphosphonates, is pointless and could be misleading.

In postmenopausal women, routine monitoring of bone mineral density in the first three years after beginning bisphosphonate therapy is not warranted and may be misleading, according to a report in the June 24th Online First issue of BMJ.

OBJECTIVE: To assess the value of monitoring response to bisphosphonate treatment by means of measuring bone mineral density.

Monitoring bone density in older women after they've started taking drugs to prevent osteoporosis is unnecessary and could be potentially misleading, researchers say.

June 24, 2009 -- Bone mineral density testing is not helpful and may even be misleading during osteoporosis treatment with bisphosphonates, new research shows.

Monitoring bone density in older women who are taking anti-osteoporosis drugs is a waste of time and money, scientists said today.

The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: A comparison of studies in the United States, the United Kingdom, and France Clinical Therapeutics , Vol.

What are good options for osteoporosis meds? I am a healthy and fit 55-year-old woman.

I am a 67-year-old woman living with osteoporosis. I have been using Forteo since Oct.

Diet, exercise, and vitamins are very important in maintaining healthy bones. Sometimes, though, this is not enough and your doctor will prescribe you medications that he thinks is right for you body.

Posted By geejaye 23 hours, 17 minutes ago in Health & Fitness Osteoporosis is a very common problem.

All ISS systems continue to function nominally, except those noted previously or below.

DEAR DR. DONOHUE: My husband has a problem with psoriasis. He is taking methotrexate, two 2.5 mg tablets, twice a week.

We're bombarded with messages about building bone all the time. How many times have you heard Sally Field talk about how her bone density increased after taking Boniva? May marks Osteoporosis Awareness Month, and this year, let's shift the focus from increasing bone density to reducing fracture risk .

Merck joined with Elsevier to publish several issues of a "fake" journal of bone disease and physiology, called the Australasian Journal of Bone and Joint Medicine back in 2003-2004. The journal placed advertisements for Fosamax and Vioxx, two Merck products, among reprints from journals such as Lancet , and opinion pieces waxing about medical ...

Consumer Reports says TV commercials for Roche and GlaxoSmithKline 's Boniva osteoporosis treatment are "misleading." The watchdog group has road-tested a bunch of drug ads and not liked what it found.

ARLINGTON, Va. The American healthcare system has saved more than half of $1 trillion over the last decade from using generic drugs, according to a study released Thursday.

All ISS systems continue to function nominally, except those noted previously or below.

Two new studies find no evidence that bisphosphonate drugs raise the risk of esophageal cancer.

Two new studies find that the class of osteoporosis drugs known as bisphosphonates may not, in fact, raise the risk of esophageal cancer.